Legal & General Group’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Legal & General Group’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,500	Closed	-$94K	–	3321
2016 Q3	$94K	Hold	4,500	–	–	﹤0.01%	2242
2016 Q2	$49K	Buy	+4,500	New	+$38.5K	﹤0.01%	2492

Legal & General Group's VTAE Position: Q4 2016 in Review

Legal & General Group sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 4,500 shares — an estimated $94K sold.

Legal & General Group first reported a position in VTAE in Q2 2016 and held it in 2 quarters. The position peaked at $94K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Legal & General Group reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Legal & General Group sold 4,500 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $94K.
Legal & General Group first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2016 and held it in 2 quarters.
Legal & General Group's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $94K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Legal & General Group's 13F filing for Q4 2016, filed 13 Feb 2017.